These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 31652837)

  • 21. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
    Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY
    Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autotaxin-LPA receptor axis in the pathogenesis of lung diseases.
    Chu X; Wei X; Lu S; He P
    Int J Clin Exp Med; 2015; 8(10):17117-22. PubMed ID: 26770305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation.
    Kostadinova L; Shive CL; Anthony DD
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31769428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.
    Enooku K; Uranbileg B; Ikeda H; Kurano M; Sato M; Kudo H; Maki H; Koike K; Hasegawa K; Kokudo N; Yatomi Y
    PLoS One; 2016; 11(9):e0161825. PubMed ID: 27583415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.
    Zhao Y; Hasse S; Zhao C; Bourgoin SG
    Biochem Pharmacol; 2019 Jun; 164():74-81. PubMed ID: 30928673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
    Willier S; Butt E; Grunewald TG
    Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.
    Rancoule C; Viaud M; Gres S; Viguerie N; Decaunes P; Bouloumié A; Langin D; Bascands JL; Valet P; Saulnier-Blache JS
    Biochim Biophys Acta; 2014 Jan; 1841(1):88-96. PubMed ID: 24120919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
    Ninou I; Kaffe E; Müller S; Budd DC; Stevenson CS; Ullmer C; Aidinis V
    Pulm Pharmacol Ther; 2018 Oct; 52():32-40. PubMed ID: 30201409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis.
    Bain G; Shannon KE; Huang F; Darlington J; Goulet L; Prodanovich P; Ma GL; Santini AM; Stein AJ; Lonergan D; King CD; Calderon I; Lai A; Hutchinson JH; Evans JF
    J Pharmacol Exp Ther; 2017 Jan; 360(1):1-13. PubMed ID: 27754931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
    Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor-Negative Mammary Epithelial Cell Proliferation.
    Volden PA; Skor MN; Johnson MB; Singh P; Patel FN; McClintock MK; Brady MJ; Conzen SD
    Cancer Prev Res (Phila); 2016 May; 9(5):367-78. PubMed ID: 26862086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression.
    Benesch MG; Wu R; Rog CJ; Brindley DN; Ishikawa T; Takabe K
    Am J Cancer Res; 2024; 14(8):4004-4027. PubMed ID: 39267662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications.
    Drosouni A; Panagopoulou M; Aidinis V; Chatzaki E
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding.
    Stein AJ; Bain G; Prodanovich P; Santini AM; Darlington J; Stelzer NM; Sidhu RS; Schaub J; Goulet L; Lonergan D; Calderon I; Evans JF; Hutchinson JH
    Mol Pharmacol; 2015 Dec; 88(6):982-92. PubMed ID: 26371182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
    D'Souza K; Paramel GV; Kienesberger PC
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn's Disease Through the ATX-LPA Axis.
    Huang L; Qian W; Xu Y; Guo Z; Yin Y; Guo F; Zhu W; Li Y
    J Crohns Colitis; 2022 Aug; 16(7):1124-1139. PubMed ID: 35104318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of lysophosphatidic acid metabolism in oral cancer promotes cell migration via the up-regulation of COX-2.
    Abdul Rahman M; Tan ML; Johnson SP; Hollows RJ; Chai WL; Mansell JP; Yap LF; Paterson IC
    PeerJ; 2020; 8():e10328. PubMed ID: 33240646
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Wang S; Chen J; Guo XZ
    World J Gastrointest Oncol; 2022 Aug; 14(8):1388-1405. PubMed ID: 36160748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.